Cost Analysis of High-Flow Oxygen Therapy Compared with Conventional Oxygen Therapy in Severe COVID-19 in Colombia: Data from a Randomized Clinical Trial.
Sergio I PradaMaria P Garcia-GarciaGustavo A Ospina-TascónDiego RosselliPublished in: ClinicoEconomics and outcomes research : CEOR (2023)
For patients in ICU with severe COVID-19 the cost of treatment with HFOT as compared to COT is likely to be cost-saving due to less use of medications and length of stay in ICU.
Keyphrases
- coronavirus disease
- sars cov
- intensive care unit
- end stage renal disease
- ejection fraction
- early onset
- chronic kidney disease
- mechanical ventilation
- prognostic factors
- electronic health record
- stem cells
- big data
- respiratory syndrome coronavirus
- patient reported outcomes
- drug induced
- artificial intelligence
- deep learning